Abstract Brachytherapy (BT), using low-dose-rate (LDR) permanent seed implantation or
high-dose-rate (HDR) temporary source implantation, is an acceptable treatment option for …

Low‐dose rate brachytherapy has become a mainstream treatment option for men
diagnosed with prostate cancer because of excellent long‐term treatment outcomes in low …

Brachytherapy delivers the most conformal high dose radiotherapy possible to the prostate,
using either a low dose rate (LDR) or high dose rate (HDR) technique. It may be used either …

Purpose: Permanent low-dose-rate (LDR-BT) and temporary high-dose-rate (HDR-BT)
brachytherapy are competitive techniques for clinically localized prostate radiotherapy …

Purpose Patients diagnosed with localized prostate cancer face a myriad of established
treatment options including active surveillance, radical prostatectomy, external beam …

Studies of dose-escalated external beam radiation therapy (EBRT) and low dose rate
brachytherapy (LDR-BT) have shown excellent rates of tumor control and cancer specific …

PURPOSE: To report the toxicity profile of high-dose-rate (HDR)-brachytherapy (BT) as
monotherapy in a Human Investigation Committee-approved study consisting of a single …

Over the past two decades, brachytherapy has played an ever expanding role in the
definitive radiotherapy of prostate cancer. Brachytherapy surpasses external beam …

PURPOSE: A well-established body of literature supports the use of high-dose-rate (HDR)
brachytherapy as definitive treatment for localized prostate cancer. Most of the articles …

Background To evaluate early urinary (GU) and gastrointestinal (GI) adverse events (AEs)
after two or one fraction of high-dose rate brachytherapy (HDR-BT) in advanced prostate …